Skip to main content

Advertisement

Log in

Beta-blockers in vascular surgery patients: is the debate still going on?

  • Review Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 27 July 2017

Abstract

Patients undergoing vascular surgery are under increased risk for perioperative myocardial ischemia and cardiovascular complications, and optimal medical treatment is therefore imperative for these patients. Beta-blockade has been introduced as a cornerstone of optimal management, and standardized preoperative initiation has been recommended in the past. However, recent pooled data have questioned prior recommendations and have led to revision of international guidelines. This review aims to highlight the debate on perioperative beta-blockade for vascular surgery patients in order to produce useful conclusions for everyday clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Høgh A, Lindholt JS, Nielsen H, Jensen LP, Johnsen SP. Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study. Eur J Vasc Endovasc Surg. 2013;46:93–102.

    Article  PubMed  Google Scholar 

  2. Bauer SM, Cayne NS, Veith FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg. 2010;51:242–51.

    Article  PubMed  Google Scholar 

  3. Flu WJ, Schouten O, van Kuijk JP, Poldermans D. Perioperative cardiac damage in vascular surgery patients. Eur J Vasc Endovasc Surg. 2010;40:1–8.

    Article  PubMed  Google Scholar 

  4. Priebe HJ. Perioperative myocardial infarction—aetiology and prevention. Br J Anaesth. 2005;95:3–19.

    Article  PubMed  Google Scholar 

  5. Paravastu SC, Mendonca DA, Silva A. Beta blockers for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2009;38:66–70.

    Article  CAS  PubMed  Google Scholar 

  6. Kadoi Y, Saito S. Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia. J Anesth. 2010;24:81–95.

    Article  PubMed  Google Scholar 

  7. Flu WJ, van Kuijk JP, Chonchol M, Winkel TA, Verhagen HJ, Bax JJ, Poldermans D. Timing of pre-operative beta-blocker treatment in vascular surgery patients: influence on post-operative outcome. J Am Coll Cardiol. 2010;56:1922–9.

    Article  PubMed  Google Scholar 

  8. Mudumbai SC, Wagner T, Mahajan S, King R, Heidenreich PA, Hlatky M, Wallace A, Mariano ER. Vascular surgery patients prescribed preoperative β-blockers experienced a decrease in the maximal heart rate observed during induction of general anesthesia. J Cardiothorac Vasc Anesth. 2012;26:414–9.

    Article  CAS  PubMed  Google Scholar 

  9. Mudumbai SC, Wagner T, Mahajan S, King R, Heidenreich PA, Hlatky M, Wallace AW, Mariano ER. Effectiveness of preoperative beta-blockade on intra-operative heart rate in vascular surgery cases conducted under regional or local anesthesia. Springerplus. 2014;3:227.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Scali S, Bertges D, Neal D, Patel V, Eldrup-Jorgensen J, Cronenwett J, Beck A. Heart rate variables in the vascular quality initiative are not reliable predictors of adverse cardiac outcomes or mortality after major elective vascular surgery. J Vasc Surg. 2015;62:710–20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Zwissler B, American Hospital Association, American College of Cardiology. Preoperative evaluation of cardiac risk patients for non-cardiac surgery. New guidelines of the ACC/AHA 2007. Anaesthesist. 2008;57:717–9.

    Article  CAS  PubMed  Google Scholar 

  12. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41:602–9.

    Article  CAS  PubMed  Google Scholar 

  13. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983–90.

    Article  CAS  PubMed  Google Scholar 

  14. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P, POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839–47.

    Article  CAS  PubMed  Google Scholar 

  15. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100:456–64.

    Article  PubMed  Google Scholar 

  16. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341(24):1789–94.

    Article  CAS  PubMed  Google Scholar 

  17. Mostafaie K, Bedenis R, Harrington D. Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery. Cochrane Database Syst Rev. 2015;1:CD006342.

  18. Scali S, Patel V, Neal D, Bertges D, Ho K, Jorgensen JE, Cronenwett J, Beck A. Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful. J Vasc Surg. 2015;62:166–76.

    Article  PubMed  Google Scholar 

  19. Florea A, van Vlymen J, Ali S, Day AG, Parlow J. Preoperative beta blocker use associated with cerebral ischemia during carotid endarterectomy. Can J Anaesth. 2014;61:819–25.

    Article  PubMed  Google Scholar 

  20. Katznelson R, Djaiani G, Mitsakakis N, Lindsay TF, Tait G, Friedman Z, Wasowicz M, Beattie WS. Delirium following vascular surgery: increased incidence with preoperative beta-blocker administration. Can J Anaesth. 2009;56:793–801.

    Article  PubMed  Google Scholar 

  21. Matyal R, Mahmood F, Panzica P, Pomposelli F, Park KW, Hamden A, Schermerhorn M, Hess P. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs. J Cardiothorac Vasc Anesth. 2008;22:354–60.

    Article  PubMed  Google Scholar 

  22. Bertges DJ, Goodney PP, Zhao Y, Schanzer A, Nolan BW, Likosky DS, Eldrup-Jorgensen J, Cronenwett JL, Vascular Study Group of New England. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg. 2010;52:674–83.

    Article  PubMed  Google Scholar 

  23. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN, American College of Cardiology, American Heart Association. ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;2014(64):77–137.

    Article  Google Scholar 

  24. Brooke BS. Perioperative beta-blockers for vascular surgery patients. J Vasc Surg. 2010;51:515–9.

    Article  PubMed  Google Scholar 

  25. Feringa HH, Bax JJ, Schouten O, Kertai MD, van de Ven LL, Hoeks S, van Sambeek MR, Klein J, Poldermans D. Beta-blockers improve in-hospital and long-term survival in patients with severe left ventricular dysfunction undergoing major vascular surgery. Eur J Vasc Endovasc Surg. 2006;31:351–8.

    Article  CAS  PubMed  Google Scholar 

  26. Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D. Beta-blocker treatment does not worsen critical limb ischemia in patients receiving endovascular therapy. J Atheroscler Thromb. 2015;22:481–9.

    Article  CAS  PubMed  Google Scholar 

  27. Obeid T, Arhuidese I, Gaidry A, Qazi U, Abularrage C, Goodney P, Cronenwett J, Malas M. Beta-blocker use is associated with lower stroke and death after carotid artery stenting. J Vasc Surg. 2016;63:363–9.

    Article  PubMed  Google Scholar 

  28. Landoni G, Turi S, Biondi-Zoccai G, Bignami E, Testa V, Belloni I, Cornero G, Zangrillo A. Esmolol reduces perioperative ischemia in noncardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth. 2010;24:219–29.

    Article  CAS  PubMed  Google Scholar 

  29. Galyfos G, Tsioufis C, Theodorou D, Katsaragakis S, Zografos G, Filis K. Cardiac troponin I after carotid endarterectomy in different cardiac risk patients. J Stroke Cerebrovasc Dis. 2015;24:711–7.

    Article  PubMed  Google Scholar 

  30. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C, Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.

    Article  PubMed  Google Scholar 

  31. Wiest DB, Haney JS. Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clin Pharmacokinet. 2012;51:347–56.

    Article  CAS  PubMed  Google Scholar 

  32. Er F, Dahlem KM, Nia AM, Erdmann E, Waltenberger J, Hellmich M, Kuhr K, Le MT, Herrfurth T, Taghiyev Z, Biesenbach E, Yüksel D, Eran-Ergöknil A, Vanezi M, Caglayan E, Gassanov N. Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction: The BEtA-blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) trial. JACC Cardiovasc Interv. 2016;9:231–40.

    Article  PubMed  Google Scholar 

  33. Suttner S, Boldt J, Mengistu A, Lang K, Mayer J. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients. Br J Anaesth. 2009;102:597–607.

    Article  CAS  PubMed  Google Scholar 

  34. Park H, Otani H, Noda T, Sato D, Okazaki T, Ueyama T, Iwasaka J, Yamamoto Y, Iwasaka T. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention. Int J Cardiol. 2013;167:1547–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George Galyfos.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galyfos, G., Filis, K., Sigala, F. et al. Beta-blockers in vascular surgery patients: is the debate still going on?. J Anesth 30, 1031–1036 (2016). https://doi.org/10.1007/s00540-016-2232-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-016-2232-z

Keywords

Navigation